CCL20-CCR6 Signaling as a Prognostic Biomarker and Therapeutic Target in Temozolomide-Resistant Glioblastoma
Ryan J. Green, Karthick Mayilsamy, Erin Anglin…·Subhra Mohapatra
This study identifies CCL20-CCR6 signaling as a prognostic biomarker and therapeutic target in temozolomide-resistant glioblastoma, showing that its inhibition enhances treatment response and induces tumor cell death.